Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Hee Jin Cho
Affiliation
Touro College of Osteopathic Medicine
ORCID
Career Start Year
2007
Papers
91
H Index
26
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36938206
Management of Post-Viral Postural Orthostatic Tachycardia Syndrome With Craniosacral Therapy.
Cureus
2023
37747920
Three-Dimensional MoS<sub>2</sub>/MXene Heterostructure Aerogel for Chemical Gas Sensors with Superior Sensitivity and Stability.
ACS Nano
2023
37822214
Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection.
Clin Mol Hepatol
2023
37537946
A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification.
Cancer Med
2023
37322445
Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study.
BMC Gastroenterol
2023
37451272
Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling.
Cancer Cell
2023
37196991
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma.
Clin Mol Hepatol
2023
36925930
Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients.
Front Oncol
2023
35337274
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis.
BMC Gastroenterol
2022
36307405
ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer.
Nat Commun
2022
35885659
Correlation between Results of Semi-Quantitative and Quantitative Tests for Hepatitis B Virus Surface Antigen among Patients Achieving Viral Suppression with Antiviral Treatment.
Diagnostics (Basel)
2022
36006905
Nanofiber Composites as Highly Active and Robust Anodes for Direct-Hydrocarbon Solid Oxide Fuel Cells.
ACS Nano
2022
35265193
Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1.
Theranostics
2022
33378179
Synergistic Interactions of Different Electroactive Components for Superior Lithium Storage Performance.
ACS Appl Mater Interfaces
2021
33828082
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma.
Cell Death Dis
2021
33846173
Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer.
Cancer Discov
2021
34885118
Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular Carcinoma.
Cancers (Basel)
2021
34471425
Comprehensive molecular profiling to predict clinical outcomes in pancreatic cancer.
Ther Adv Med Oncol
2021
34342046
Confinement of Ultrasmall Bimetallic Nanoparticles in Conductive Metal-Organic Frameworks via Site-Specific Nucleation.
Adv Mater
2021
33975862
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer.
Clin Cancer Res
2021
31096737
Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas.
Cancer Res Treat
2020
32045199
Multifunctional Inorganic Nanomaterial Aerogel Assembled into fSWNT Hydrogel Platform for Ultraselective NO<sub>2</sub> Sensing.
ACS Appl Mater Interfaces
2020
32070411
Comprehensive pharmacogenomic characterization of gastric cancer.
Genome Med
2020
31822064
Pore-Size-Tuned Graphene Oxide Membrane as a Selective Molecular Sieving Layer: Toward Ultraselective Chemiresistors.
Anal Chem
2020
33224274
Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment.
Ther Adv Med Oncol
2020
33392508
Tumor edge-to-core transition promotes malignancy in primary-to-recurrent glioblastoma progression in a PLAGL1/CD109-mediated mechanism.
Neurooncol Adv
2020
33124428
Chemiresistive Hydrogen Sensors: Fundamentals, Recent Advances, and Challenges.
ACS Nano
2020
32605068
Multi-Habitat Radiomics Unravels Distinct Phenotypic Subtypes of Glioblastoma with Clinical and Genomic Significance.
Cancers (Basel)
2020
32938908
Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy.
Nat Commun
2020
32794373
Ethnic delineation of primary glioblastoma genome.
Cancer Med
2020
32620753
Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities.
Nat Commun
2020
32847614
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.
Genome Biol
2020
32120790
Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening.
Cancers (Basel)
2020
32510574
MDSC subtypes and CD39 expression on CD8<sup>+</sup> T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC.
Eur J Immunol
2020
30898893
PIP4K2A as a negative regulator of PI3K in PTEN-deficient glioblastoma.
J Exp Med
2019
29939324
Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.
Neuro Oncol
2019
30085274
Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma.
Neuro Oncol
2019
29316430
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
Cancer Cell
2018
30022047
Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells.
Cell Death Dis
2018
29989640
Chitosan-templated Pt nanocatalyst loaded mesoporous SnO<sub>2</sub> nanofibers: a superior chemiresistor toward acetone molecules.
Nanoscale
2018
29924610
Scorpionate Catalysts for Coupling CO<sub>2</sub> and Epoxides to Cyclic Carbonates: A Rational Design Approach for Organocatalysts.
J Org Chem
2018
30343896
Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor.
Cell
2018
30264562
Pt-Functionalized PdO Nanowires for Room Temperature Hydrogen Gas Sensors.
ACS Sens
2018
30262818
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.
Nat Genet
2018
29608265
Facile Synthesis of Pt-Functionalized Meso/Macroporous SnO<sub>2</sub> Hollow Spheres through in Situ Templating with SiO<sub>2</sub> for H<sub>2</sub>S Sensors.
ACS Appl Mater Interfaces
2018
29573206
Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma.
Cancer Med
2018
29762012
Bioinspired Cocatalysts Decorated WO<sub>3</sub> Nanotube Toward Unparalleled Hydrogen Sulfide Chemiresistor.
ACS Sens
2018
29129044
Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.
Cancer Res Treat
2018
28758254
Exceptional High-Performance of Pt-Based Bimetallic Catalysts for Exclusive Detection of Exhaled Biomarkers.
Adv Mater
2017
28481075
Innovative Nanosensor for Disease Diagnosis.
Acc Chem Res
2017
1 - 50 of 91
Column Actions
Search
Recommended Authors
Meixiao Zhan
Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)
Career Start Year
2013
Number of shared co-authors
0
Zhao Li
College of Plant Science, Jilin University
Career Start Year
2013
Number of shared co-authors
0
Gen Li
Research Center for Nano-Biomaterials, Sichuan University
Career Start Year
2013
Number of shared co-authors
0
Young-Won Kim
Baylor College of Medicine
Career Start Year
2009
Number of shared co-authors
3
Nan Qin
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Career Start Year
2007
Number of shared co-authors
1
Ke Jin
West China Hospital, Sichuan University
Career Start Year
2005
Number of shared co-authors
0
Fei Teng
Ningbo First Hospital
Career Start Year
2004
Number of shared co-authors
1
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year
2004
Number of shared co-authors
0
Fan Mo
Institute of Stem Cell and Regeneration, Chinese Academy of Sciences
Career Start Year
2004
Number of shared co-authors
0
Nan Du
Institute for Solid State Physics, Friedrich Schiller University Jena
Career Start Year
2003
Number of shared co-authors
0
Bing Bai
Hefei National Laboratory, University of Science and Technology of China
Career Start Year
2002
Number of shared co-authors
0
Hsin-Yi Wang
Taipei Veterans General Hospital
Career Start Year
2002
Number of shared co-authors
0
Yu-Chuan Chang
Chang Gung Memorial Hospital-Linko, Chang Gung University
Career Start Year
2002
Number of shared co-authors
0
Dae Hwan Kim
Nanoori Gangnam Hospital
Career Start Year
2001
Number of shared co-authors
1
Yen-Lin Chen
34903Fu-Jen Catholic University
Career Start Year
2001
Number of shared co-authors
1
Deng Pan
College of Plant Protection, Southwest University
Career Start Year
2001
Number of shared co-authors
0
Tiannan Guo
Westlake University
Career Start Year
2001
Number of shared co-authors
0
Ji Eun Lee
Soonchunhyang University College of Medicine, Bucheon Hospital
Career Start Year
1999
Number of shared co-authors
7
Sun Young Lee
Chonbuk National University Hospital
Career Start Year
1998
Number of shared co-authors
5
Woo Young Kim
Westchester Medical Center
Career Start Year
1998
Number of shared co-authors
3
Rong Fan
Institute of Pathogens and Vectors, Dali University
Career Start Year
1998
Number of shared co-authors
0
Jin Young Lee
Samsung Medical Center, College of Medicine, The Sungkyunkwan University of Korea
Career Start Year
1997
Number of shared co-authors
2
Chun-Liang Chen
National Dong Hwa University
Career Start Year
1997
Number of shared co-authors
0
Hyo Jin Kim
Department of Food Bioengineering, Jeju National University
Career Start Year
1996
Number of shared co-authors
3
Ning Guo
Beijing Tongren Hospital, Capital Medical University
Career Start Year
1995
Number of shared co-authors
0
Hyun-Soo Kim
Wonju Severance Christian Hospital
Career Start Year
1993
Number of shared co-authors
5
Mei He
Sichuan University
Career Start Year
1992
Number of shared co-authors
0
Bing Xia
Xijing Hospital, The Fourth Military Medical University
Career Start Year
1992
Number of shared co-authors
0
Dong Wook Kim
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Career Start Year
1992
Number of shared co-authors
5
Tian Tian
Beijing Friendship Hospital, Capital Medical University
Career Start Year
1988
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers
32
Jason K Sa
Korea University, College of Medicine
Co-authored papers
17
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers
12
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
12
Jeongwu Lee
Lerner Research Institute, Cleveland Clinic
Co-authored papers
11
Doo-Sik Kong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
10
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers
9
Harim Koo
Korea University College of Medicine
Co-authored papers
8
Donggeon Kim
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers
8
Yong Jae Shin
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers
8
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
7
Sung Tae Kim
Busan Paik Hospital, Inje University
Co-authored papers
7
Seung Won Choi
Samsung Medical Center, Sungkyunkwan University
Co-authored papers
7
Yun Jee Seo
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers
7
Jin-Ku Lee
Seoul National University, College of Medicine
Co-authored papers
6
Hyemi Shin
Research Institute for Future Medicine, Samsung Medical Center
Co-authored papers
6
Yeup Yoon
Sungkyunkwan University
Co-authored papers
6
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers
6
Hye Won Lee
Yonsei University College of Medicine, Severance Hospital
Co-authored papers
5
Joon Oh Park
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
5
Jung Won Choi
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
4
Kyoung-Mee Kim
Seoul National University College of Medicine
Co-authored papers
4
Misuk Kim
Inha University
Co-authored papers
4
Roel G W Verhaak
Yale School of Medicine
Co-authored papers
4
In-Hee Lee
Co-authored papers
3
Hyun Ju Kang
Genomic Medicine Institute, Medical Research Center, Seoul National University
Co-authored papers
3
Chul-Kee Park
College of Medicine, Seoul National University
Co-authored papers
3
Jong Bae Park
Henan-Macquarie University Joint Centre for Biomedical Innovation, Henan University
Co-authored papers
3
Sung Heon Kim
Sungkyunkwan University
Co-authored papers
3
Sung Soo Kim
Institute of Vision Research, Yonsei University College of Medicine
Co-authored papers
3
1 - 30